Development of New Plasma-Derived Pharmaceutical Product Portfolio This Year
Nojin Zist Pharmed’s pharmaceutical portfolio is developing new clinical treatment options in line with maximizing the coverage of the country’s therapeutic needs.
July 29, 2026
Read More →